High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation
| Autor: | K Falke, Herwig Gerlach, O. Hoffmann, D. J. M. Frey, U. Keske, D. Pappert, K. Lewandowski, K. Slama, R Rossaint, H. Weidemann |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Adult
Male ARDS medicine.medical_specialty Membrane oxygenator medicine.medical_treatment Critical Care and Intensive Care Medicine Statistics Nonparametric Extracorporeal Membrane Oxygenation Risk Factors Cause of Death Germany Intensive care Extracorporeal membrane oxygenation Humans Medicine Prospective Studies Prospective cohort study Survival analysis Mechanical ventilation Respiratory Distress Syndrome APACHE II business.industry medicine.disease Survival Analysis Surgery Research Design Female business Algorithms |
| Zdroj: | Intensive Care Medicine. 23:819-835 |
| ISSN: | 1432-1238 0342-4642 |
| DOI: | 10.1007/s001340050418 |
| Popis: | Objective: We investigated whether a treatment according to a clinical algorithm could improve the low survival rates in acute respiratory distress syndrome (ARDS). Design: Uncontrolled prospective trial. Setting: One university hospital intensive care department. Patients and participants: 122 patients with ARDS, consecutively admitted to the ICU. Interventions: ARDS was treated according to a criteria-defined clinical algorithm. The algorithm distinguished two main treatment groups: The AT-sine-ECMO (advanced treatment without extracorporeal membrane oxygenation) group (n = 73) received a treatment consisting of a set of advanced non-invasive treatment options, the ECMO treatment group (n = 49) received additional extracorporeal membrane oxygenation (ECMO) using heparin-coated systems. Measurements and results: The groups differed in both APACHE II (16 ± 5 vs 18 ± 5 points, p = 0.01) and Murray scores (3.2 ± 0.3 vs 3.4 ± 0.3 points, p = 0.0001), the duration of mechanical ventilation prior to admission (10 ± 9 vs 13 ± 9 days, p = 0.0151), and length of ICU stay in Berlin (31 ± 17 vs 50 ± 36 days, p = 0.0016). Initial PaO2/FIO2 was 86 ± 27 mm Hg in AT-sine-ECMO patients that improved to 165 ± 107 mm Hg on ICU day 1, while ECMO patients showed an initial PaO2/FIO2 of 67 ± 28 mm Hg and improvement to 160 ± 102 mm Hg was not reached until ICU day 13. Q˙S/Q˙T was significantly higher in the ECMO-treated group and exceeded 50 % during the first 14 ICU days. The overall survival rate in our 122 ARDS patients was 75 %. Survival rates were 89 % in the AT-sine ECMO group and 55 % in the ECMO treatment group (p = 0.0000). Conclusions: We conclude that patients with ARDS can be successfully treated with the clinical algorithm and high survival rates can be achieved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink